Arcutis Biotherapeutics, Inc. (ARQT)
USD 13.4
(-9.83%)
USD 13.4
(-9.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -247.05 Million | -257.71 Million | -174.62 Million | -113.03 Million | -42.83 Million | -14.08 Million |
| Net Income | -262.14 Million | -311.45 Million | -206.35 Million | -135.67 Million | -41.99 Million | -19.25 Million |
| Depreciation & Amortization | 1.88 Million | 934 Thousand | 454 Thousand | 122 Thousand | 195 Thousand | - |
| Deferred income taxes | 19.81 Million | - | 3.45 Million | 114 Thousand | - | - |
| Stock-based compensation | 38.81 Million | 32.68 Million | 23.89 Million | 7.94 Million | 824 Thousand | 151 Thousand |
| Change in working capital | -23.5 Million | -10.17 Million | 3.62 Million | 14.13 Million | -1.5 Million | 2.1 Million |
| Other non-cash items | -21.92 Million | 30.3 Million | 309 Thousand | 333 Thousand | -354 Thousand | 2.91 Million |
| Investing Cash Flow | 180.23 Million | -87.19 Million | -75.95 Million | -181.82 Million | -26.32 Million | -11.53 Million |
| Investments in PPE | -428 Thousand | -23.28 Million | -995 Thousand | -321 Thousand | -295 Thousand | - |
| Acquisitions | -180.66 Million | 22.95 Million | 74.95 Million | 181.5 Million | 26.03 Million | - |
| Investment purchases | -225.84 Million | -415.38 Million | -292.5 Million | -279.1 Million | -60.83 Million | -11.53 Million |
| Sales/Maturities of investments | 406.5 Million | 351.47 Million | 217.55 Million | 97.6 Million | 34.8 Million | - |
| Other Investing Activities | 180.66 Million | -22.95 Million | -74.95 Million | -181.5 Million | -26.03 Million | -11.53 Million |
| Financing Cash Flow | 101.32 Million | 301.79 Million | 281.94 Million | 298.14 Million | 93.1 Million | 61.59 Million |
| Debt repayment | - | -122.81 Million | -72.35 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 12.46 Million | 842 Thousand | 617 Thousand | - | - |
| Common Stock Issuance | 101.32 Million | 178.98 Million | 209.59 Million | 298.14 Million | 94.23 Million | 61.59 Million |
| Other Financing Activities | 5.55 Million | -2.18 Million | -1.63 Million | 298.14 Million | -1.13 Million | 61.59 Million |
| Accounts receivables | -17.34 Million | -8.45 Million | - | - | - | - |
| Accounts payables | 3.15 Million | 1.56 Million | 245 Thousand | 5.67 Million | -458 Thousand | 1.26 Million |
| Inventory | -5.62 Million | -7.51 Million | - | - | - | - |
| Other working capital | -3.68 Million | 4.23 Million | 3.37 Million | 8.45 Million | -1.04 Million | 844 Thousand |
| Cash at beginning of period | 54.87 Million | 97.99 Million | 66.62 Million | 63.33 Million | 39.39 Million | 3.41 Million |
| Cash at end of period | 89.32 Million | 54.87 Million | 97.99 Million | 66.62 Million | 63.33 Million | 39.39 Million |
| Capital Expenditure | -428 Thousand | -23.28 Million | -995 Thousand | -321 Thousand | -295 Thousand | - |
| Effect of forex changes on cash | -50 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | 34.44 Million | -43.11 Million | 31.36 Million | 3.28 Million | 23.94 Million | 35.97 Million |
| Free Cash Flow | -247.48 Million | -280.99 Million | -175.62 Million | -113.35 Million | -43.13 Million | -14.08 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -52.33 Million | -35.38 Million | -262.14 Million | -66.28 Million | -44.76 Million | -70.99 Million |
| Depreciation & Amortization | 351 Thousand | 358 Thousand | 1.88 Million | 385 Thousand | 387 Thousand | 386 Thousand |
| Deferred income taxes | - | - | 19.81 Million | -16.33 Million | -1.53 Million | -1.82 Million |
| Stock-based compensation | 12.52 Million | 10.03 Million | 38.81 Million | 8.75 Million | 9.99 Million | 10.57 Million |
| Change in working capital | -4.26 Million | -5.44 Million | -23.5 Million | 411 Thousand | -9.18 Million | -5.72 Million |
| Other non-cash items | 22.8 Million | 20.04 Million | -21.92 Million | 16.81 Million | 1.1 Million | 1.09 Million |
| Investing Cash Flow | -62.13 Million | -28.69 Million | 180.23 Million | -62.18 Million | 45.54 Million | 89.11 Million |
| Investments in PPE | - | - | -428 Thousand | -6000.00 | -64 Thousand | -276 Thousand |
| Acquisitions | - | - | -180.66 Million | 62.18 Million | -45.61 Million | -89.39 Million |
| Investment purchases | -125.77 Million | -105.95 Million | -225.84 Million | -118.18 Million | -22.38 Million | -45.6 Million |
| Sales/Maturities of investments | 63.63 Million | 77.25 Million | 406.5 Million | 56 Million | 68 Million | 135 Million |
| Other Investing Activities | -62.13 Million | -28.69 Million | 180.66 Million | -62.18 Million | 45.61 Million | 89.39 Million |
| Financing Cash Flow | 1.45 Million | 161.76 Million | 101.32 Million | 99.28 Million | 867 Thousand | 1.06 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.45 Million | 161.76 Million | 101.32 Million | 99.28 Million | 867 Thousand | 1.06 Million |
| Other Financing Activities | 1.45 Million | 82 Thousand | 5.55 Million | 99.28 Million | 867 Thousand | 1.06 Million |
| Accounts receivables | -5.17 Million | -11.34 Million | -17.34 Million | -6.39 Million | -2.21 Million | -4.43 Million |
| Accounts payables | -5.16 Million | 992 Thousand | 3.15 Million | -1.19 Million | -3.97 Million | 4.94 Million |
| Inventory | -633 Thousand | -113 Thousand | -5.62 Million | 779 Thousand | -3.43 Million | -1.92 Million |
| Other working capital | 6.7 Million | 5.02 Million | -3.68 Million | 7.21 Million | 443 Thousand | -4.3 Million |
| Cash at beginning of period | 190.71 Million | 89.32 Million | 54.87 Million | 108.39 Million | 106.03 Million | 82.33 Million |
| Cash at end of period | 84.88 Million | 190.71 Million | 89.32 Million | 89.32 Million | 108.39 Million | 106.03 Million |
| Capital Expenditure | - | - | -428 Thousand | -6000.00 | -64 Thousand | -276 Thousand |
| Effect of forex changes on cash | -26 Thousand | -73 Thousand | -50 Thousand | 68 Thousand | -75 Thousand | 9000.00 |
| Net cash flow / Change in cash | -105.82 Million | 101.39 Million | 34.44 Million | -19.07 Million | 2.35 Million | 23.7 Million |
| Free Cash Flow | -45.11 Million | -31.6 Million | -247.48 Million | -56.25 Million | -44.04 Million | -66.76 Million |
SMR-WT
BSPM
ANG
INDIANVSH
1008
300173